QC
VTVT icon

Quadrature Capital’s vTv Therapeutics VTVT Stock Holding History

Quadrature Capital’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+6,305
New +$219K ﹤0.01% 1296

Other funds holding VTVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
VNA
Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Quadrature Capital's VTVT Position: Q2 2026 in Review

Quadrature Capital opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 6,305 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #1296 among its holdings.

12 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Quadrature Capital held 6,305 shares of vTv Therapeutics worth $237K as of Q2 2026.
  • vTv Therapeutics was a new Quadrature Capital position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1296 holding.
  • 12 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.